1
|
Qi C, Cheng L, Huang C. Artificial Trachea from Microtissue Engineering and Three-Dimensional Printing for Tracheal Personalized Repair. Tissue Eng Part A 2024; 30:393-403. [PMID: 38265006 DOI: 10.1089/ten.tea.2023.0171] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2024] Open
Abstract
Millions of people suffer from tracheal defect worldwide each year, while autograft and allograft cannot meet existing treatment needs. Tissue-engineered trachea substitutes represent a promising treatment for tracheal defect, while lack of precisely personalized treatment abilities. Therefore, development of an artificial trachea that can be used for personalized transplantation is highly desired. In this study, we report the design and fabrication of an artificial trachea based on sericin microsphere (SM) by microtissue engineering technology and three-dimensional (3D) printing for personalized repair of tracheal defect. The SM possessed natural cell adhesion and promoting cell proliferation ability. Then, the microtissue was fabricated by coincubation of SM with chondrocytes and tracheal epithelial cells. This microtissue displayed good cytocompatibility and could support seed cell adhesion and proliferation. After that, this microtissue was individually assembled to form an artificial trachea by 3D printing. Notably, artificial trachea had an encouraging complete cartilaginous and epithelial structure after transplantation. Furthermore, the artificial trachea molecularly resembled native trachea as evidenced by similar expression of trachea-critical genes. Altogether, the work demonstrates the effectiveness of microtissue engineering and 3D printing for individual construction of artificial trachea, providing a promising approach for personalized treatment of tracheal defect.
Collapse
Affiliation(s)
- Chao Qi
- Department of Pharmacy, Wuhan No.1 Hospital, Wuhan, China
| | - Lu Cheng
- Department of Pharmacy, Wuhan No.1 Hospital, Wuhan, China
| | - Chuanqi Huang
- Department of Pharmacy, Wuhan No.1 Hospital, Wuhan, China
| |
Collapse
|
2
|
Amaral VA, de Souza JF, Alves TFR, de Oliveira Junior JM, Severino P, Aranha N, Souto EB, Chaud MV. Psidium guajava L. phenolic compound-reinforced lamellar scaffold for tracheal tissue engineering. Drug Deliv Transl Res 2024; 14:62-79. [PMID: 37566362 PMCID: PMC10746760 DOI: 10.1007/s13346-023-01381-0] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 06/16/2023] [Indexed: 08/12/2023]
Abstract
The aim of this work was to develop a dense lamellar scaffold, as a biomimetic material with potential applications in the regeneration of tracheal tissue after surgical tumor resection. The scaffolds were produced by plastic compression technique, exploiting the use of total phenolic compounds (TPC) from Psidium guajava Linn as a potential cross-linking agent in a polymeric mixture based on collagen (COL), silk fibroin (SF), and polyethylene glycol 400 (PEG 400). Fourier transform infrared spectroscopy (FTIR) and differential scanning calorimetry (DSC) confirmed the chemical interactions between the polymers and the cross-linking of TPC between COL and SF. Morphological analyses showed scaffolds with porosity, interconnectivity, and a porous surface structure with a gyroid-like geometry. The analysis of the anisotropic degree resulted in anisotropic structures (0.1% TFC and 0.3% TFC) and an isotropic structure (0.5% TFC). In the mechanical properties, it was evidenced greater resistance for the 0.3% TFC formulation. The addition of TPC percentages did not result in a significant difference (p > 0.05) in swelling capacity and disintegration rate. The results confirmed that TPC were able to modulate the morphological, morphometric, and mechanical properties of scaffolds. Thus, this study describes a potential new material to improve the regeneration of major tracheal structures after surgical tumor removal.
Collapse
Affiliation(s)
- Venâncio A Amaral
- Laboratory of Biomaterials and Nanotechnology, University of Sorocaba, UNISO, Raposo Tavares, Sorocaba, São Paulo, 18023-000, Brazil
| | - Juliana Ferreira de Souza
- Laboratory of Biomaterials and Nanotechnology, University of Sorocaba, UNISO, Raposo Tavares, Sorocaba, São Paulo, 18023-000, Brazil
| | - Thais F R Alves
- Laboratory of Biomaterials and Nanotechnology, University of Sorocaba, UNISO, Raposo Tavares, Sorocaba, São Paulo, 18023-000, Brazil
| | - José M de Oliveira Junior
- Laboratory of Applied Nuclear Physics, University of Sorocaba, UNISO, Raposo Tavares, Sorocaba, São Paulo, 18023-000, Brazil
| | - Patrícia Severino
- Institute of Technology and Research, Tiradentes University, Murilo Dantas, Aracaju, Sergipe, 300, Brazil
| | - Norberto Aranha
- Laboratory of Biomaterials and Nanotechnology, University of Sorocaba, UNISO, Raposo Tavares, Sorocaba, São Paulo, 18023-000, Brazil
- College of Engineering of Bioprocess and Biotechnology, University of Sorocaba, UNISO, Raposo Tavares, Sorocaba, 18023-000, Brazil
| | - Eliana B Souto
- Laboratory of Pharmaceutical Technology, Department of Drug Sciences, Faculty of Pharmacy, University of Porto, Jorge de Viterbo Ferreira, 4050-313, Porto, Portugal.
- MEDTECH, Department of Drug Sciences, Faculty of Pharmacy, University of Porto, 4050-313, Porto, Portugal.
- Associate Laboratory i4HB-Institute for Health and Bioeconomy, Faculty of Pharmacy, University of Porto, 4050-313, Porto, Portugal.
| | - Marco V Chaud
- Laboratory of Biomaterials and Nanotechnology, University of Sorocaba, UNISO, Raposo Tavares, Sorocaba, São Paulo, 18023-000, Brazil.
- College of Engineering of Bioprocess and Biotechnology, University of Sorocaba, UNISO, Raposo Tavares, Sorocaba, 18023-000, Brazil.
| |
Collapse
|
3
|
Khalid T, Soriano L, Lemoine M, Cryan SA, O’Brien FJ, O’Leary C. Development of tissue-engineered tracheal scaffold with refined mechanical properties and vascularisation for tracheal regeneration. Front Bioeng Biotechnol 2023; 11:1187500. [PMID: 37346796 PMCID: PMC10281188 DOI: 10.3389/fbioe.2023.1187500] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/16/2023] [Accepted: 05/04/2023] [Indexed: 06/23/2023] Open
Abstract
Introduction: Attempted tracheal replacement efforts thus far have had very little success. Major limiting factors have been the inability to efficiently re-vascularise and mimic the mechanical properties of native tissue. The major objective of this study was to optimise a previously developed collagen-hyaluronic acid scaffold (CHyA-B), which has shown to facilitate the growth of respiratory cells in distinct regions, as a potential tracheal replacement device. Methods: A biodegradable thermoplastic polymer was 3D-printed into different designs and underwent multi-modal mechanical assessment. The 3D-printed constructs were incorporated into the CHyA-B scaffolds and subjected to in vitro and ex vivo vascularisation. Results: The polymeric backbone provided sufficient strength to the CHyA-B scaffold, with yield loads of 1.31-5.17 N/mm and flexural moduli of 0.13-0.26 MPa. Angiogenic growth factor release (VEGF and bFGF) and angiogenic gene upregulation (KDR, TEK-2 and ANG-1) was detected in composite scaffolds and remained sustainable up to 14 days. Confocal microscopy and histological sectioning confirmed the presence of infiltrating blood vessel throughout composite scaffolds both in vitro and ex vivo. Discussion: By addressing both the mechanical and physiological requirements of tracheal scaffolds, this work has begun to pave the way for a new therapeutic option for large tracheal defects.
Collapse
Affiliation(s)
- Tehreem Khalid
- School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland
- Tissue Engineering Research Group, RCSI University of Medicine and Health Sciences, Dublin, Ireland
- Advanced Materials and Bioengineering Research (AMBER) Centre, RCSI and Trinity College Dublin, Dublin, Ireland
| | - Luis Soriano
- School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland
- Tissue Engineering Research Group, RCSI University of Medicine and Health Sciences, Dublin, Ireland
- Centre for Research in Biomedical Devices (CÚRAM), NUI Galway, Galway, Ireland
| | - Mark Lemoine
- Tissue Engineering Research Group, RCSI University of Medicine and Health Sciences, Dublin, Ireland
- Advanced Materials and Bioengineering Research (AMBER) Centre, RCSI and Trinity College Dublin, Dublin, Ireland
- Trinity Centre for Biomedical Engineering, Trinity College Dublin, Dublin, Ireland
| | - Sally-Ann Cryan
- School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland
- Tissue Engineering Research Group, RCSI University of Medicine and Health Sciences, Dublin, Ireland
- Advanced Materials and Bioengineering Research (AMBER) Centre, RCSI and Trinity College Dublin, Dublin, Ireland
- Centre for Research in Biomedical Devices (CÚRAM), NUI Galway, Galway, Ireland
- Trinity Centre for Biomedical Engineering, Trinity College Dublin, Dublin, Ireland
| | - Fergal J. O’Brien
- Tissue Engineering Research Group, RCSI University of Medicine and Health Sciences, Dublin, Ireland
- Advanced Materials and Bioengineering Research (AMBER) Centre, RCSI and Trinity College Dublin, Dublin, Ireland
- Centre for Research in Biomedical Devices (CÚRAM), NUI Galway, Galway, Ireland
- Trinity Centre for Biomedical Engineering, Trinity College Dublin, Dublin, Ireland
| | - Cian O’Leary
- School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland
- Tissue Engineering Research Group, RCSI University of Medicine and Health Sciences, Dublin, Ireland
- Advanced Materials and Bioengineering Research (AMBER) Centre, RCSI and Trinity College Dublin, Dublin, Ireland
| |
Collapse
|
4
|
Wang Y, Li J, Qian J, Sun Y, Xu J, Sun J. Comparison of the biological properties between 3D-printed and decellularized tracheal grafts. Bioprocess Biosyst Eng 2023:10.1007/s00449-023-02867-4. [PMID: 37171579 DOI: 10.1007/s00449-023-02867-4] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/26/2022] [Accepted: 03/21/2023] [Indexed: 05/13/2023]
Abstract
This study sought to characterize the differences between the 3D-printed and decellularized tracheal grafts, providing the basis for the synthesis of the more reasonable and effective tissue-engineered trachea. We compared the biomechanical properties and biocompatibility of the 3D-printed tracheal graft and decellularized tracheal graft in vitro and evaluated the biocompatibility, immune rejection and inflammation of the two materials through in vivo implantation experiments. Compared with the decellularized tracheal graft, the 3D-printed tracheal graft was associated with obviously higher biomechanical properties. The results demonstrated enhanced growth of BMSCs in the decellularized tracheal graft compared to the 3D-printed one when co-culture with two tracheal graft groups. Moreover, the CCK-8 assay demonstrated significant cell proliferation on the decellularized tracheal graft. Serum IgG and IgM measured in vivo by implantation testing indicated that the 3D-Printed tracheal graft exhibited the most significant inflammatory response. HE staining indicated that the inflammatory response in the 3D-printed tracheal graft consisted mainly of eosinophils, while little inflammatory cell infiltrates were observed in the decellularized tracheal graft. CD68 immunohistochemical analysis indicated that the infiltration of macrophages was not significant in both tracheal grafts. Our findings suggest that the biomechanical properties of the 3D-printed tracheal grafts are better than the decellularized tracheal grafts. Nonetheless, the decellularized tracheal graft exhibited better biocompatibility than the 3D-printed tracheal graft.
Collapse
Affiliation(s)
- Yao Wang
- Department of Cardiothoracic Surgery, Yancheng First Hospital, Affiliated Hospital of Nanjing University Medical School, Yancheng, 224005, China
| | - Jianfeng Li
- Yizheng Hospital, Drum Tower Hospital Group of Nanjing, Yizheng, 211900, China
| | - Jun Qian
- Department of Cardiothoracic Surgery, Yancheng First Hospital, Affiliated Hospital of Nanjing University Medical School, Yancheng, 224005, China
| | - Yunhao Sun
- Department of Cardiothoracic Surgery, Yancheng First Hospital, Affiliated Hospital of Nanjing University Medical School, Yancheng, 224005, China
| | - Jianning Xu
- Department of Cardiothoracic Surgery, Yancheng First Hospital, Affiliated Hospital of Nanjing University Medical School, Yancheng, 224005, China
| | - Jian Sun
- Department of Cardiothoracic Surgery, Yancheng First Hospital, Affiliated Hospital of Nanjing University Medical School, Yancheng, 224005, China.
| |
Collapse
|
5
|
Zhang B, Sun F, Lu Y, Wang Z, Shen Z, Yuan L, Wu Q, Wu C, Shi H. A Novel Decellularized Trachea Preparation Method for Rapid Construction of a Functional Tissue Engineered Trachea to Repair Tracheal Defects. J Mater Chem B 2022; 10:4810-4822. [PMID: 35237780 DOI: 10.1039/d1tb02100a] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Long segment trachea defects are repaired by tracheal substitution, while the decellularized technology has been effectively employed to prepare tissue engineering trachea (TET). However, its clinical application is restrictied by...
Collapse
Affiliation(s)
- Boyou Zhang
- The Department of Thoracic Surgery, The Second Xiangya Hospital, Central South University, Changsha, China
- Clinical Medical College, Yangzhou University, No. 98 Nantong West Road, Yangzhou, Jiangsu 225009, P. R. China.
- Northern Jiangsu People's Hospital Affiliated Hospital to Yangzhou University, Yangzhou, China
- Jiangsu Key Laboratory of Integrated Traditional Chinese and Western Medicine for Prevention and Treatment of Senile Diseases, Yangzhou University, Yangzhou, China
| | - Fei Sun
- Clinical Medical College, Yangzhou University, No. 98 Nantong West Road, Yangzhou, Jiangsu 225009, P. R. China.
- Northern Jiangsu People's Hospital Affiliated Hospital to Yangzhou University, Yangzhou, China
- Jiangsu Key Laboratory of Integrated Traditional Chinese and Western Medicine for Prevention and Treatment of Senile Diseases, Yangzhou University, Yangzhou, China
| | - Yi Lu
- Clinical Medical College, Yangzhou University, No. 98 Nantong West Road, Yangzhou, Jiangsu 225009, P. R. China.
- Northern Jiangsu People's Hospital Affiliated Hospital to Yangzhou University, Yangzhou, China
- Jiangsu Key Laboratory of Integrated Traditional Chinese and Western Medicine for Prevention and Treatment of Senile Diseases, Yangzhou University, Yangzhou, China
| | - Zhihao Wang
- Clinical Medical College, Yangzhou University, No. 98 Nantong West Road, Yangzhou, Jiangsu 225009, P. R. China.
- Northern Jiangsu People's Hospital Affiliated Hospital to Yangzhou University, Yangzhou, China
- Jiangsu Key Laboratory of Integrated Traditional Chinese and Western Medicine for Prevention and Treatment of Senile Diseases, Yangzhou University, Yangzhou, China
| | - Zhiming Shen
- Clinical Medical College, Yangzhou University, No. 98 Nantong West Road, Yangzhou, Jiangsu 225009, P. R. China.
- Northern Jiangsu People's Hospital Affiliated Hospital to Yangzhou University, Yangzhou, China
- Jiangsu Key Laboratory of Integrated Traditional Chinese and Western Medicine for Prevention and Treatment of Senile Diseases, Yangzhou University, Yangzhou, China
| | - Lei Yuan
- Clinical Medical College, Yangzhou University, No. 98 Nantong West Road, Yangzhou, Jiangsu 225009, P. R. China.
- Northern Jiangsu People's Hospital Affiliated Hospital to Yangzhou University, Yangzhou, China
- Jiangsu Key Laboratory of Integrated Traditional Chinese and Western Medicine for Prevention and Treatment of Senile Diseases, Yangzhou University, Yangzhou, China
| | - Qiang Wu
- The Department of Thoracic Surgery, The Second Xiangya Hospital, Central South University, Changsha, China
- Clinical Medical College, Yangzhou University, No. 98 Nantong West Road, Yangzhou, Jiangsu 225009, P. R. China.
- Northern Jiangsu People's Hospital Affiliated Hospital to Yangzhou University, Yangzhou, China
- Jiangsu Key Laboratory of Integrated Traditional Chinese and Western Medicine for Prevention and Treatment of Senile Diseases, Yangzhou University, Yangzhou, China
| | - Cong Wu
- Clinical Medical College, Yangzhou University, No. 98 Nantong West Road, Yangzhou, Jiangsu 225009, P. R. China.
- Northern Jiangsu People's Hospital Affiliated Hospital to Yangzhou University, Yangzhou, China
- Jiangsu Key Laboratory of Integrated Traditional Chinese and Western Medicine for Prevention and Treatment of Senile Diseases, Yangzhou University, Yangzhou, China
| | - Hongcan Shi
- Clinical Medical College, Yangzhou University, No. 98 Nantong West Road, Yangzhou, Jiangsu 225009, P. R. China.
- Northern Jiangsu People's Hospital Affiliated Hospital to Yangzhou University, Yangzhou, China
- Jiangsu Key Laboratory of Integrated Traditional Chinese and Western Medicine for Prevention and Treatment of Senile Diseases, Yangzhou University, Yangzhou, China
- The Department of Thoracic Surgery, The Second Xiangya Hospital, Central South University, Changsha, China
| |
Collapse
|
6
|
Sun F, Lu Y, Wang Z, Zhang B, Shen Z, Yuan L, Wu C, Wu Q, Yang W, Zhang G, Pan Z, Shi H. Directly construct microvascularization of tissue engineering trachea in orthotopic transplantation. MATERIALS SCIENCE & ENGINEERING. C, MATERIALS FOR BIOLOGICAL APPLICATIONS 2021; 128:112201. [PMID: 34474813 DOI: 10.1016/j.msec.2021.112201] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/23/2020] [Revised: 05/10/2021] [Accepted: 05/17/2021] [Indexed: 12/17/2022]
Abstract
Tissue engineering technology provides effective alternative treatments for tracheal reconstruction. The formation of a functional microvascular network is essential to support cell metabolism and ensure the long-term survival of grafts. However, given the lack of an identifiable vascular pedicle of the trachea that could be anastomosed to the blood vessels directly in the recipient's neck, successful tracheal transplantation faces significant challenges in rebuilding the adequate blood supply of the graft. Herein, we describe a one-step method to construct microvascularization of tissue-engineered trachea in orthotopic transplantation. Forty rabbit tracheae were decellularized using a vacuum-assisted decellularization (VAD) method. Histological appearance and immunohistochemical (IHC) analysis demonstrated efficient removal of cellular components and nuclear material from natural tissue, which was also confirmed by 4'-6-diamidino-2-phenylindole(DAPI) staining and DNA quantitative analysis, thus significantly reducing the antigenicity. Scanning electron microscopy (SEM), immunofluorescence (IF) analysis, GAG and collagen quantitative analysis showed that the hierarchical structures, composition and integrity of the extracellular matrix (ECM) were protected. IF analysis also demonstrated that basic fibroblast growth factor (b-FGF) was preserved during the decellularization process, and also exerted biocompatibility and proangiogenic properties by the chick chorioallantoic membrane(CAM) assay. Xenotransplantation assays indicated that the VAD tracheal matrix would no longer induced inflammatory reactions implanted in the body for 4 weeks after treated by VAD more than 16 h. Furthermore, we seeded the matrix with bone marrow-derived endothelial cells (BMECs) in vitro and performed in vivo tracheal patch repair assays to prove the biocompatibility and neovascularization of VAD-treated tracheal matrix, and the formation of a vascular network around the patch promoted the crawling of surrounding ciliated epithelial cells to the surface of the graft. We conclude that this natural VAD tracheal matrix is non-immunogenic and no inflammatory reactions in vivo transplantation. Seeding with BMECs on the grafts and then performing orthotopic transplantation can effectively promote the microvascularization and accelerate the native epithelium cells crawling to the lumen of the tracheal graft.
Collapse
Affiliation(s)
- Fei Sun
- Institute of Translational Medicine, Medical College, Yangzhou University, Yangzhou 225001, China; Clinical Medical College, Yangzhou University, Yangzhou 225001, China; Jiangsu Key Laboratory of Integrated Traditional Chinese and Western Medicine for Prevention and Treatment of Senile Diseases, Yangzhou University, Yangzhou 225001, China
| | - Yi Lu
- Institute of Translational Medicine, Medical College, Yangzhou University, Yangzhou 225001, China; Clinical Medical College, Yangzhou University, Yangzhou 225001, China; Jiangsu Key Laboratory of Integrated Traditional Chinese and Western Medicine for Prevention and Treatment of Senile Diseases, Yangzhou University, Yangzhou 225001, China
| | - Zhihao Wang
- Institute of Translational Medicine, Medical College, Yangzhou University, Yangzhou 225001, China; Clinical Medical College, Yangzhou University, Yangzhou 225001, China; Jiangsu Key Laboratory of Integrated Traditional Chinese and Western Medicine for Prevention and Treatment of Senile Diseases, Yangzhou University, Yangzhou 225001, China
| | - Boyou Zhang
- Clinical Medical College, Yangzhou University, Yangzhou 225001, China; Jiangsu Key Laboratory of Integrated Traditional Chinese and Western Medicine for Prevention and Treatment of Senile Diseases, Yangzhou University, Yangzhou 225001, China; The Second Xiangya Hospital, Central South University, Changsha 410011, China
| | - Zhiming Shen
- Institute of Translational Medicine, Medical College, Yangzhou University, Yangzhou 225001, China; Clinical Medical College, Yangzhou University, Yangzhou 225001, China; Jiangsu Key Laboratory of Integrated Traditional Chinese and Western Medicine for Prevention and Treatment of Senile Diseases, Yangzhou University, Yangzhou 225001, China
| | - Lei Yuan
- Institute of Translational Medicine, Medical College, Yangzhou University, Yangzhou 225001, China; Clinical Medical College, Yangzhou University, Yangzhou 225001, China; Jiangsu Key Laboratory of Integrated Traditional Chinese and Western Medicine for Prevention and Treatment of Senile Diseases, Yangzhou University, Yangzhou 225001, China
| | - Cong Wu
- Institute of Translational Medicine, Medical College, Yangzhou University, Yangzhou 225001, China; Clinical Medical College, Yangzhou University, Yangzhou 225001, China; Jiangsu Key Laboratory of Integrated Traditional Chinese and Western Medicine for Prevention and Treatment of Senile Diseases, Yangzhou University, Yangzhou 225001, China
| | - Qiang Wu
- Clinical Medical College, Yangzhou University, Yangzhou 225001, China; Jiangsu Key Laboratory of Integrated Traditional Chinese and Western Medicine for Prevention and Treatment of Senile Diseases, Yangzhou University, Yangzhou 225001, China; The Second Xiangya Hospital, Central South University, Changsha 410011, China
| | - Wenlong Yang
- Institute of Translational Medicine, Medical College, Yangzhou University, Yangzhou 225001, China; Clinical Medical College, Yangzhou University, Yangzhou 225001, China; Jiangsu Key Laboratory of Integrated Traditional Chinese and Western Medicine for Prevention and Treatment of Senile Diseases, Yangzhou University, Yangzhou 225001, China
| | - Guozhong Zhang
- Institute of Translational Medicine, Medical College, Yangzhou University, Yangzhou 225001, China; Clinical Medical College, Yangzhou University, Yangzhou 225001, China; Jiangsu Key Laboratory of Integrated Traditional Chinese and Western Medicine for Prevention and Treatment of Senile Diseases, Yangzhou University, Yangzhou 225001, China
| | - Ziyin Pan
- Institute of Translational Medicine, Medical College, Yangzhou University, Yangzhou 225001, China; Jiangsu Key Laboratory of Integrated Traditional Chinese and Western Medicine for Prevention and Treatment of Senile Diseases, Yangzhou University, Yangzhou 225001, China
| | - Hongcan Shi
- Institute of Translational Medicine, Medical College, Yangzhou University, Yangzhou 225001, China; Clinical Medical College, Yangzhou University, Yangzhou 225001, China; Jiangsu Key Laboratory of Integrated Traditional Chinese and Western Medicine for Prevention and Treatment of Senile Diseases, Yangzhou University, Yangzhou 225001, China.
| |
Collapse
|
7
|
Sun F, Lu Y, Wang Z, Shi H. Vascularization strategies for tissue engineering for tracheal reconstruction. Regen Med 2021; 16:549-566. [PMID: 34114475 DOI: 10.2217/rme-2020-0091] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/05/2023] Open
Abstract
Tissue engineering technology provides effective alternative treatments for tracheal reconstruction. The formation of a functional microvascular network is essential to support cell metabolism and ensure the long-term survival of grafts. Although several tracheal replacement therapy strategies have been developed in the past, the critical significance of the formation of microvascular networks in 3D scaffolds has not attracted sufficient attention. Here, we review key technologies and related factors of microvascular network construction in tissue-engineered trachea and explore optimized preparation processes of vascularized functional tissues for clinical applications.
Collapse
Affiliation(s)
- Fei Sun
- Clinical Medical College, Yangzhou University, Yangzhou, 225001, PR China.,Institute of Translational Medicine, Medical College, Yangzhou University, Yangzhou, 225001, PR China.,Jiangsu Key Laboratory of Integrated Traditional Chinese & Western Medicine for Prevention & Treatment of Senile Diseases, Yangzhou University, Yangzhou, 225001, PR China
| | - Yi Lu
- Clinical Medical College, Yangzhou University, Yangzhou, 225001, PR China.,Institute of Translational Medicine, Medical College, Yangzhou University, Yangzhou, 225001, PR China.,Jiangsu Key Laboratory of Integrated Traditional Chinese & Western Medicine for Prevention & Treatment of Senile Diseases, Yangzhou University, Yangzhou, 225001, PR China
| | - Zhihao Wang
- Clinical Medical College, Yangzhou University, Yangzhou, 225001, PR China.,Institute of Translational Medicine, Medical College, Yangzhou University, Yangzhou, 225001, PR China.,Jiangsu Key Laboratory of Integrated Traditional Chinese & Western Medicine for Prevention & Treatment of Senile Diseases, Yangzhou University, Yangzhou, 225001, PR China
| | - Hongcan Shi
- Clinical Medical College, Yangzhou University, Yangzhou, 225001, PR China.,Institute of Translational Medicine, Medical College, Yangzhou University, Yangzhou, 225001, PR China.,Jiangsu Key Laboratory of Integrated Traditional Chinese & Western Medicine for Prevention & Treatment of Senile Diseases, Yangzhou University, Yangzhou, 225001, PR China
| |
Collapse
|
8
|
Wang Z, Sun F, Lu Y, Pan S, Yang W, Zhang G, Ma J, Shi H. Rapid preparation of decellularized trachea as a 3D scaffold for organ engineering. Int J Artif Organs 2020; 44:55-64. [PMID: 32448040 DOI: 10.1177/0391398820924041] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Abstract
OBJECTIVE To shorten the preparation time of rabbit decellularized tracheal matrix through a modified detergent-enzymatic method with higher concentration of DNase (50 kU/mL), providing an experimental and theoretical basis for clinical decellularization technology. METHODS The control group was a natural trachea, and the experimental group was a tracheal matrix subjected to two and four decellularization cycles. The performance of each group of samples was evaluated by histology and immunohistochemical staining, scanning electron microscopy, biomechanical property testing, inoculation and cytotoxicity tests, and allograft experiments. RESULTS The results showed that the nuclei of the nonchondral areas of the tracheal stroma were essentially completely removed and MHC-I and MHC-II antigens were removed after two decellularization cycles. Histological staining and scanning electron microscopy showed that the extracellular matrix was retained and the basement membrane was intact. Cell inoculation and proliferation tests confirmed that the acellular tracheal matrix had good biocompatibility, and the proliferation capacity of bone mesenchymal stem cells on the matrix was increased in the experimental group compared with the control group (p < 0.05). Histological staining and CD68 molecular marker analysis after the allograft experiment showed that the inflammatory response of the acellular tracheal matrix was weak and the infiltration of surrounding macrophages was reduced. CONCLUSION A modified detergent-enzymatic method with an increased DNase (50 kU/mL) concentration requires only two cycles (4 days) to obtain a decellularized rabbit tracheal matrix with a short preparation time, good biocompatibility, suitable mechanical properties, and reduced preparation cost.
Collapse
Affiliation(s)
- Zhihao Wang
- Department of Cardiothoracic Surgery, College of Clinical Medicine, Yangzhou University, Yangzhou, China
- The Research Center for Translational Medicine, Yangzhou University, Yangzhou, China
| | - Fei Sun
- Department of Cardiothoracic Surgery, College of Clinical Medicine, Yangzhou University, Yangzhou, China
- The Research Center for Translational Medicine, Yangzhou University, Yangzhou, China
- The Hospital Affiliated to Medical School of Yangzhou University (Taizhou People's Hospital), Taizhou, China
| | - Yi Lu
- Department of Cardiothoracic Surgery, College of Clinical Medicine, Yangzhou University, Yangzhou, China
- The Research Center for Translational Medicine, Yangzhou University, Yangzhou, China
| | - Shu Pan
- Department of Cardiothoracic Surgery, College of Clinical Medicine, Yangzhou University, Yangzhou, China
- The Research Center for Translational Medicine, Yangzhou University, Yangzhou, China
- Department of Thoracic Surgery, First Affiliated Hospital of Soochow University, Suzhou, China
| | - Wenlong Yang
- Department of Cardiothoracic Surgery, College of Clinical Medicine, Yangzhou University, Yangzhou, China
- The Research Center for Translational Medicine, Yangzhou University, Yangzhou, China
| | - Guozhong Zhang
- Department of Cardiothoracic Surgery, College of Clinical Medicine, Yangzhou University, Yangzhou, China
- The Research Center for Translational Medicine, Yangzhou University, Yangzhou, China
| | - Jun Ma
- Department of Cardiothoracic Surgery, College of Clinical Medicine, Yangzhou University, Yangzhou, China
- The Research Center for Translational Medicine, Yangzhou University, Yangzhou, China
| | - Hongcan Shi
- Department of Cardiothoracic Surgery, College of Clinical Medicine, Yangzhou University, Yangzhou, China
- The Research Center for Translational Medicine, Yangzhou University, Yangzhou, China
| |
Collapse
|
9
|
Lee SJ, Choi JS, Eom MR, Jo HH, Kwon IK, Kwon SK, Park SA. Dexamethasone loaded bilayered 3D tubular scaffold reduces restenosis at the anastomotic site of tracheal replacement: in vitro and in vivo assessments. NANOSCALE 2020; 12:4846-4858. [PMID: 32016227 DOI: 10.1039/c9nr10341d] [Citation(s) in RCA: 18] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/21/2023]
Abstract
Despite recent developments in the tracheal tissue engineering field, the creation of a patient specific substitute possessing both appropriate mechanical and biointerfacial properties remains challenging. Most tracheal replacement therapies fail due to restenosis at the anastomosis site. In this study, we designed a robust, biodegradable, 3D tubular scaffold by combining electrospinning (ELSP) and 3D (three-dimensional) printing techniques for use in transplantation therapy. After that, we loaded dexamethasone (DEX) onto the 3D tubular scaffold using mild surface modification reactions by using polydopamine (PDA), polyethyleneimine (PEI), and carboxymethyl-β-cyclodextrin (βCD). As a result, the fabricated 3D tubular scaffold had robust mechanical properties and the chemical modifications were confirmed to have proceeded successfully by physico-chemical analysis. The surface treatments allowed for a larger amount of DEX to be loaded onto the βCD modified scaffold as compared to the bare group. In vitro and in vivo studies demonstrated that the DEX loaded 3D tubular scaffold exhibited significantly enhanced anti-inflammation activity, enhanced tracheal mucosal regeneration, and formation of a patent airway. From our results, we believe that our system may represent an innovative paradigm in tracheal tissue engineering by providing proper mechanical properties and successful formation of tracheal tissue as a means of remodeling and healing tracheal defects for use in transplantation therapy.
Collapse
Affiliation(s)
- Sang Jin Lee
- Department of Nature-Inspired Nanoconvergence Systems, Korea Institute of Machinery and Materials, 156 Gajeongbuk-ro, Yuseong-gu, Daejeon 34103, Republic of Korea. and Department of Dental Materials, School of Dentistry, Kyung Hee University, 26 Kyungheedae-ro, Dongdaemun-gu, Seoul 02447, Republic of Korea
| | - Ji Suk Choi
- Department of Otorhinolaryngology-Head and Neck Surgery, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.
| | - Min Rye Eom
- Department of Otorhinolaryngology-Head and Neck Surgery, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.
| | - Ha Hyeon Jo
- Department of Nature-Inspired Nanoconvergence Systems, Korea Institute of Machinery and Materials, 156 Gajeongbuk-ro, Yuseong-gu, Daejeon 34103, Republic of Korea.
| | - Il Keun Kwon
- Department of Dental Materials, School of Dentistry, Kyung Hee University, 26 Kyungheedae-ro, Dongdaemun-gu, Seoul 02447, Republic of Korea
| | - Seong Keun Kwon
- Department of Otorhinolaryngology-Head and Neck Surgery, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea. and Department of Otorhinolaryngology-Head and Neck Surgery, Seoul National University College of Medicine, Seoul, Republic of Korea
| | - Su A Park
- Department of Nature-Inspired Nanoconvergence Systems, Korea Institute of Machinery and Materials, 156 Gajeongbuk-ro, Yuseong-gu, Daejeon 34103, Republic of Korea.
| |
Collapse
|
10
|
Facile Fabrication of Composite Scaffolds for Long-Term Controlled Dual Drug Release. ADVANCES IN POLYMER TECHNOLOGY 2020. [DOI: 10.1155/2020/3927860] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
Bone tuberculosis (TB) caused by mycobacterium tuberculosis continues to present a formidable challenge to humans. To effectively cure serious bone TB, a novel kind of composite scaffolds with long-term dual drug release behaviours were prepared to satisfy the needs of both bone regeneration and antituberculosis drug therapy. In virtue of an improved O/W emulsion technique, water-soluble isoniazid (INH)-loaded gelatin microparticles were obtained by tailoring the content of β-tricalcium phosphate (β-TCP), which played significant roles in INH entrapment efficiency and drug release behaviours. By mixing with the poly(ε-caprolactone)-block-poly (lactic-co-glycolic acid) (b-PLGC) solution containing oil-soluble rifampicin (RFP) via the particle leaching combined with phase separation technique, the dual drugs-loaded composite scaffolds were fabricated, which possessed interconnected porous structures and achieved the steady release of INH and RFP drugs for three months. Moreover, this dual drugs-loaded system could basically achieve their expectant roles of respective drugs without obvious influences with each other. This strategy on preparation of intelligent composite scaffolds with the multi-drugs loading capacity and controlled long-term release behaviour will be potential and promising substrates in clinical treatment of bone tuberculosis.
Collapse
|
11
|
Lu T, Huang Y, Qiao Y, Zhang Y, Liu Y. Evaluation of changes in cartilage viability in detergent-treated tracheal grafts for immunosuppressant-free allotransplantation in dogs. Eur J Cardiothorac Surg 2019; 53:672-679. [PMID: 28958037 DOI: 10.1093/ejcts/ezx317] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/31/2017] [Accepted: 08/09/2017] [Indexed: 11/12/2022] Open
Abstract
OBJECTIVES The first tissue-engineered clinical tracheal transplant prepared using the detergent-enzymatic method resulted in graft stenosis, possibly from detergent-enzymatic method-induced graft non-viability. We reported on the transplantation of de-epithelialized tracheal allografts while maintaining cartilage viability in dogs. No lethal stenosis occurred in allografts. Herein, on the basis of previous experimentation, we assessed cartilage viability in detergent-treated cartilages. METHODS Six canine tracheal grafts were treated with detergent [1% t-octylphenoxypolyethoxyethanol (Triton X-100)] before transplantation. The histoarchitecture was evaluated, and the viable chondrocytes ratio was calculated. Glycosaminoglycan was detected using safranin-O staining. Collagen II was tested using immunohistochemistry. RESULTS The epithelium was completely removed in 5 grafts. Compared with fresh tracheas, the viable chondrocyte ratio was significantly reduced in the de-epithelialized grafts (100 vs 54.70 ± 8.56%; P < 0.001). Image analysis revealed that the mean optical density of glycosaminoglycan (0.363 ± 0.027 vs 0.307 ± 0.012; P = 0.007) and collagen II (0.115 ± 0.013 vs 0.092 ± 0.011; P = 0.028) was decreased. The observation period ranged from 91 to 792 days. No stenosis occurred in 5 allografts; moderate stenosis developed in 1 allograft during the 4th week after surgery. The chondrocyte nuclei almost completely disappeared. Both glycosaminoglycan (0.307 ± 0.012 vs 0.164 ± 0.104; P = 0.044) and collagen II (0.092 ± 0.011 vs 0.068 ± 0.022; P = 0.022) were significantly degraded. CONCLUSIONS This study demonstrated successful tracheal transplantation; about 50% of the viable chondrocytes were retained in the cartilage that could prevent development of a lethal stenosis in tracheal grafts.
Collapse
Affiliation(s)
- Tao Lu
- Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China
| | - Yiwei Huang
- Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China
| | - Yulei Qiao
- Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China
| | - Yongxing Zhang
- Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China
| | - Yu Liu
- Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China
| |
Collapse
|
12
|
Park HS, Lee JS, Jung H, Kim DY, Kim SW, Sultan MT, Park CH. An omentum-cultured 3D-printed artificial trachea: in vivo bioreactor. ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY 2018; 46:S1131-S1140. [DOI: 10.1080/21691401.2018.1533844] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]
Affiliation(s)
- Hae Sang Park
- Department of Otorhinolaryngology–Head and Neck Surgery, Chuncheon Sacred Heart Hospital, College of Medicine, Hallym University, Chuncheon, Republic of Korea
- Institute of New Frontier Research Team, Hallym Clinical and Translation Science Institute, Hallym University, Chuncheon, Republic of Korea
| | - Ji Seung Lee
- Nano-Bio Regenerative Medical Institute, School of Medicine, Hallym University, Chuncheon, Republic of Korea
| | - Harry Jung
- Institute of New Frontier Research Team, Hallym Clinical and Translation Science Institute, Hallym University, Chuncheon, Republic of Korea
| | - Do Yeon Kim
- Nano-Bio Regenerative Medical Institute, School of Medicine, Hallym University, Chuncheon, Republic of Korea
| | - Sang Wook Kim
- Department of Otorhinolaryngology–Head and Neck Surgery, Chuncheon Sacred Heart Hospital, College of Medicine, Hallym University, Chuncheon, Republic of Korea
| | - Md. Tipu Sultan
- Nano-Bio Regenerative Medical Institute, School of Medicine, Hallym University, Chuncheon, Republic of Korea
| | - Chan Hum Park
- Department of Otorhinolaryngology–Head and Neck Surgery, Chuncheon Sacred Heart Hospital, College of Medicine, Hallym University, Chuncheon, Republic of Korea
- Nano-Bio Regenerative Medical Institute, School of Medicine, Hallym University, Chuncheon, Republic of Korea
| |
Collapse
|
13
|
Batioglu-Karaaltin A, Ovali E, Karaaltin MV, Yener M, Yılmaz M, Eyüpoğlu F, Yılmaz YZ, Bozkurt ER, Demir N, Konuk E, Bozdağ ES, Yiğit Ö, Cansiz H. Decellularization of Trachea With Combined Techniques for Tissue-Engineered Trachea Transplantation. Clin Exp Otorhinolaryngol 2018; 12:86-94. [PMID: 30326701 PMCID: PMC6315211 DOI: 10.21053/ceo.2018.00486] [Citation(s) in RCA: 30] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/03/2018] [Accepted: 07/09/2018] [Indexed: 02/04/2023] Open
Abstract
Objectives The purpose of this study is to shorten the decellularization time of trachea by using combination of physical, chemical, and enzymatic techniques. Methods Approximately 3.5-cm-long tracheal segments from 42 New Zealand rabbits (3.5±0.5 kg) were separated into seven groups according to decellularization protocols. After decellularization, cellular regions, matrix and strength and endurance of the scaffold were followed up. Results DNA content in all groups was measured under 50 ng/mg and there was no significant difference for the glycosaminoglycan content between group 3 (lyophilization+deoxycholic acid+de-oxyribonuclease method) and control group (P=0.46). None of the decellularized groups was different than the normal trachea in tensile stress values (P>0.05). Glucose consumption and lactic acid levels measured from supernatants of all decellularized groups were close to group with cells only (76 mg/dL and 53 mg/L). Conclusion Using combination methods may reduce exposure to chemicals, prevent the excessive influence of the matrix, and shorten the decellularization time.
Collapse
Affiliation(s)
- Aysegul Batioglu-Karaaltin
- Department of Otolaryngology, Head and Neck Surgery, Istanbul University Cerrahpasa Medicine Faculty, Istanbul, Turkey
| | | | - Mehmet V Karaaltin
- Department of Plastic and Reconstructive Surgery, Acibadem University School of Medicine, Istanbul, Turkey
| | - Murat Yener
- Department of Otolaryngology, Head and Neck Surgery, Istanbul University Cerrahpasa Medicine Faculty, Istanbul, Turkey
| | - Mehmet Yılmaz
- Department of Otolaryngology, Head and Neck Surgery, Istanbul University Cerrahpasa Medicine Faculty, Istanbul, Turkey
| | | | - Yetkin Zeki Yılmaz
- Department of Otolaryngology, Head and Neck Surgery, Istanbul University Cerrahpasa Medicine Faculty, Istanbul, Turkey
| | - Erol Rüştü Bozkurt
- Department of Pathology, Istanbul Education and Research Hospital, Istanbul, Turkey
| | - Necdet Demir
- Department of Histology and Embryology, Akdeniz University Medicine Faculty, Antalya, Turkey
| | - Esma Konuk
- Department of Histology and Embryology, Akdeniz University Medicine Faculty, Antalya, Turkey
| | - Ergun Süreyya Bozdağ
- Faculty of Mechanical Engineering, Department of Mechanical Engineering, Istanbul Technical University, Istanbul, Turkey
| | - Özgür Yiğit
- Department of Otolaryngology, Head and Neck Surgery, Istanbul Education and Research Hospital, Istanbul, Turkey
| | - Harun Cansiz
- Department of Otolaryngology, Head and Neck Surgery, Istanbul University Cerrahpasa Medicine Faculty, Istanbul, Turkey
| |
Collapse
|
14
|
Abstract
Trachea replacement for nonoperable defects remains an unsolved problem due to complications with stenosis and mechanical insufficiency. While native trachea has anisotropic mechanical properties, the vast majority of engineered constructs focus on uniform cartilaginous-like conduits. These conduits often lack quantitative mechanical analysis at the construct level, which limits analysis of functional outcomes in vivo, as well as comparisons across studies. This review aims to present a clear picture of native tracheal mechanics at the tissue and organ level, as well as loading conditions to establish design criteria for trachea replacements. We further explore the implications of failing to match native properties with regards to implant collapse, stenosis, and infection.
Collapse
Affiliation(s)
- Elizabeth M Boazak
- Department of Biomedical Engineering, The City College of New York, Steinman Hall, 160 Convent Avenue, New York, New York 10031, United States
| | - Debra T Auguste
- Department of Biomedical Engineering, The City College of New York, Steinman Hall, 160 Convent Avenue, New York, New York 10031, United States.,Department of Chemical Engineering, Northeastern University, 360 Huntington Avenue, Boston, Massachusetts 02115, United States
| |
Collapse
|
15
|
Zou G, Li Y, Jin Y, Zhu X, Yang J, Wang S, You Q, Xiong H, Liu Y. [ In vitrodifferentiation of human amniotic mesenchymal stem cells into ligament fibroblasts after induced by transforming growth factor β 1 and vascular endothelial growth factor]. ZHONGGUO XIU FU CHONG JIAN WAI KE ZA ZHI = ZHONGGUO XIUFU CHONGJIAN WAIKE ZAZHI = CHINESE JOURNAL OF REPARATIVE AND RECONSTRUCTIVE SURGERY 2017; 31:582-593. [PMID: 29798549 DOI: 10.7507/1002-1892.201612090] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
Objective To investigate whether human amniotic mesenchymal stem cells (hAMSCs) have the characteristics of mesenchymal stem cells (MSCs) and the differentiation capacity into ligament fibroblasts in vitro. Methods The hAMSCs were separated through trypsin and collagenase digestion from placenta, the phenotypic characteristics of hAMSCs were detected by flow cytometry, the cytokeratin-19 (CK-19) and vimentin expression of hAMSCs were tested through immunofluorescence staining. The hAMSCs at the 3rd passage were cultured with L-DMEM/F12 medium containing transforming growth factor β 1 (TGF-β 1) and vascular endothelial growth factor (VEGF) as the experimental group and with single L-DMEM/F12 medium as the control group. The morphology of hAMSCs was observed by inverted phase contrast microscope; the cellular activities and ability of proliferation were examined by cell counting kit-8 (CCK-8) method; the ligament fibroblasts related protein expressions including collagen type I, collagen type III, Fibronectin, and Tenascin-C were detected by immunofluorescence staining; specific mRNA expressions of ligament fibroblasts and angiogenesis including collagen type I, collagen type III, Fibronectin, α-smooth muscle actin (α-SMA), and VEGF were measured by real-time fluorescence quantitative PCR. Results The hAMSCs presented monolayer and adherent growth under inverted phase contrast microscope; the flow cytometry results demonstrated that hAMSCs expressed the MSCs phenotypes; the immunofluorescence staining results indicated the hAMSCs had high expression of the vimentin and low expression of CK-19; the hAMSCs possessed the differentiation ability into the osteoblasts, chondroblasts, and lipoblasts. The CCK-8 results displayed that cells reached the peak of growth curve at 7 days in each group, and the proliferation ability in the experimental group was significantly higher than that in the control group at 7 days ( P<0.05). The immunofluorescence staining results showed that the expressions of collagen type I, collagen type III, Fibronectin, and Tenascin-C in the experimental group were significantly higher than those in the control group at 5, 10, and15 days after culture ( P<0.05). The real-time fluorescence quantitative PCR results revealed that the mRNA relative expressions had an increasing tendency at varying degrees with time in the experimental group ( P<0.05). The relative mRNA expressions of collagen type I, collagen type III, Fibronectin, α-SMA, and VEGF in the experimental group were significantly higher than those in the control group at the other time points ( P<0.05), but no significant difference was found in the relative mRNA expressions of collagen type I, collagen type III, and VEGF between 2 groups at 5 days ( P>0.05). Conclusion The hAMSCs possesses the characteristics of MSCs and good proliferation ability which could be chosen as seed cell source in tissue engineering. The expressions of ligament fibroblasts and angiogenesis related genes could be up-regulated, after induction in vitro, and the synthesis of ligament fibroblasts related proteins could be strengthened. In addition, the application of TGF-β 1 and VEGF could be used as growth factors sources in constructing tissue engineered ligament.
Collapse
Affiliation(s)
- Gang Zou
- The First Department of Orthopaedics, the Affiliated Hospital of Zunyi Medical College, Zunyi Guizhou, 563000, P.R.China
| | | | - Ying Jin
- The First Department of Orthopaedics, the Affiliated Hospital of Zunyi Medical College, Zunyi Guizhou, 563000, P.R.China
| | - Xizhong Zhu
- The First Department of Orthopaedics, the Affiliated Hospital of Zunyi Medical College, Zunyi Guizhou, 563000, P.R.China
| | - Jibin Yang
- The First Department of Orthopaedics, the Affiliated Hospital of Zunyi Medical College, Zunyi Guizhou, 563000, P.R.China
| | - Shengmin Wang
- The First Department of Orthopaedics, the Affiliated Hospital of Zunyi Medical College, Zunyi Guizhou, 563000, P.R.China
| | - Qi You
- The First Department of Orthopaedics, the Affiliated Hospital of Zunyi Medical College, Zunyi Guizhou, 563000, P.R.China
| | - Huazhang Xiong
- The First Department of Orthopaedics, the Affiliated Hospital of Zunyi Medical College, Zunyi Guizhou, 563000, P.R.China
| | - Yi Liu
- The First Department of Orthopaedics, the Affiliated Hospital of Zunyi Medical College, Zunyi Guizhou, 563000,
| |
Collapse
|
16
|
Melo E, Kasper JY, Unger RE, Farré R, Kirkpatrick CJ. Development of a Bronchial Wall Model: Triple Culture on a Decellularized Porcine Trachea. Tissue Eng Part C Methods 2015; 21:909-21. [DOI: 10.1089/ten.tec.2014.0543] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- Esther Melo
- Unitat de Biofísica i Bioenginyeria, Facultat de Medicina, Universitat de Barcelona, Barcelona, Spain
- CIBER de Enfermedades Respiratorias, Bunyola, Spain
- Institut Investigacions Biomediques August Pi Sunyer, Barcelona, Spain
| | - Jennifer Y. Kasper
- Institute of Pathology, University Medical Center, Johannes-Guttenberg-University Mainz, Mainz, Germany
| | - Ronald E. Unger
- Institute of Pathology, University Medical Center, Johannes-Guttenberg-University Mainz, Mainz, Germany
| | - Ramon Farré
- Unitat de Biofísica i Bioenginyeria, Facultat de Medicina, Universitat de Barcelona, Barcelona, Spain
- CIBER de Enfermedades Respiratorias, Bunyola, Spain
- Institut Investigacions Biomediques August Pi Sunyer, Barcelona, Spain
| | - Charles James Kirkpatrick
- Institute of Pathology, University Medical Center, Johannes-Guttenberg-University Mainz, Mainz, Germany
| |
Collapse
|
17
|
Abstract
SUMMARY A recent revival of global interest for reconstruction of long-segment tracheal defects, which represents one of the most interesting and complex problems in head and neck and thoracic reconstructive surgery, has been witnessed. The trachea functions as a conduit for air, and its subunits including the epithelial layer, hyaline cartilage, and segmental blood supply make it particularly challenging to reconstruct. A myriad of attempts at replacing the trachea have been described. These along with the anatomy, indications, and approaches including microsurgical tracheal reconstruction will be reviewed. Novel techniques such as tissue-engineering approaches will also be discussed. Multiple attempts at replacing the trachea with synthetic scaffolds have been met with failure. The main lesson learned from such failures is that the trachea must not be treated as a "simple tube." Understanding the anatomy, developmental biology, physiology, and diseases affecting the trachea are required for solving this problem.
Collapse
|
18
|
Pan S, Sun F, Shi H, Zhang F, Liu X, Zhang W. Evaluation of an immune-privileged scaffold for In vivo implantation of tissue-engineered trachea. BIOTECHNOL BIOPROC E 2014. [DOI: 10.1007/s12257-014-0150-1] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/23/2023]
|
19
|
Advances in tracheal reconstruction. PLASTIC AND RECONSTRUCTIVE SURGERY-GLOBAL OPEN 2014; 2:e178. [PMID: 25426361 PMCID: PMC4229282 DOI: 10.1097/gox.0000000000000097] [Citation(s) in RCA: 36] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/29/2013] [Accepted: 03/24/2014] [Indexed: 12/26/2022]
Abstract
Summary: A recent revival of global interest for reconstruction of long-segment tracheal defects, which represents one of the most interesting and complex problems in head and neck and thoracic reconstructive surgery, has been witnessed. The trachea functions as a conduit for air, and its subunits including the epithelial layer, hyaline cartilage, and segmental blood supply make it particularly challenging to reconstruct. A myriad of attempts at replacing the trachea have been described. These along with the anatomy, indications, and approaches including microsurgical tracheal reconstruction will be reviewed. Novel techniques such as tissue-engineering approaches will also be discussed. Multiple attempts at replacing the trachea with synthetic scaffolds have been met with failure. The main lesson learned from such failures is that the trachea must not be treated as a “simple tube.” Understanding the anatomy, developmental biology, physiology, and diseases affecting the trachea are required for solving this problem.
Collapse
|
20
|
Sun F, Pan S, Shi HC, Zhang FB, Zhang WD, Ye G, Liu XC, Zhang SQ, Zhong CH, Yuan XL. Structural integrity, immunogenicity and biomechanical evaluation of rabbit decelluarized tracheal matrix. J Biomed Mater Res A 2014; 103:1509-19. [DOI: 10.1002/jbm.a.35273] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/09/2013] [Revised: 05/22/2014] [Accepted: 06/13/2014] [Indexed: 12/16/2022]
Affiliation(s)
- Fei Sun
- Department of Cardiothoracic Surgery, College of Clinical Medicine; Yangzhou University; Yangzhou 225001 Jiangsu Province China
- The Research Center for Translational Medicine, Yangzhou University; Yangzhou 225001 Jiangsu Province China
| | - Shu Pan
- Department of Cardiothoracic Surgery, College of Clinical Medicine; Yangzhou University; Yangzhou 225001 Jiangsu Province China
- The Research Center for Translational Medicine, Yangzhou University; Yangzhou 225001 Jiangsu Province China
| | - Hong-Can Shi
- Department of Cardiothoracic Surgery, College of Clinical Medicine; Yangzhou University; Yangzhou 225001 Jiangsu Province China
- The Research Center for Translational Medicine, Yangzhou University; Yangzhou 225001 Jiangsu Province China
| | - Fang-Biao Zhang
- Department of Cardiothoracic Surgery, College of Clinical Medicine; Yangzhou University; Yangzhou 225001 Jiangsu Province China
- The Research Center for Translational Medicine, Yangzhou University; Yangzhou 225001 Jiangsu Province China
| | - Wei-Dong Zhang
- Department of Cardiothoracic Surgery, College of Clinical Medicine; Yangzhou University; Yangzhou 225001 Jiangsu Province China
- The Research Center for Translational Medicine, Yangzhou University; Yangzhou 225001 Jiangsu Province China
| | - Gang Ye
- Department of Cardiothoracic Surgery, College of Clinical Medicine; Yangzhou University; Yangzhou 225001 Jiangsu Province China
- The Research Center for Translational Medicine, Yangzhou University; Yangzhou 225001 Jiangsu Province China
| | - Xing-Chen Liu
- Department of Cardiothoracic Surgery, College of Clinical Medicine; Yangzhou University; Yangzhou 225001 Jiangsu Province China
- The Research Center for Translational Medicine, Yangzhou University; Yangzhou 225001 Jiangsu Province China
| | - Si-Quan Zhang
- Department of Cardiothoracic Surgery, College of Clinical Medicine; Yangzhou University; Yangzhou 225001 Jiangsu Province China
- The Research Center for Translational Medicine, Yangzhou University; Yangzhou 225001 Jiangsu Province China
| | - Chong-Hao Zhong
- Department of Cardiothoracic Surgery, College of Clinical Medicine; Yangzhou University; Yangzhou 225001 Jiangsu Province China
- The Research Center for Translational Medicine, Yangzhou University; Yangzhou 225001 Jiangsu Province China
| | - Xiao-Long Yuan
- Department of Cardiothoracic Surgery, College of Clinical Medicine; Yangzhou University; Yangzhou 225001 Jiangsu Province China
| |
Collapse
|
21
|
Golas AR, Hernandez KA, Spector JA. Tissue engineering for plastic surgeons: a primer. Aesthetic Plast Surg 2014; 38:207-221. [PMID: 24378377 DOI: 10.1007/s00266-013-0255-5] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/08/2013] [Accepted: 11/17/2013] [Indexed: 01/12/2023]
Abstract
A central tenet of reconstructive surgery is the principle of "replacing like with like." However, due to limitations in the availability of autologous tissue or because of the complications that may ensue from harvesting it, autologous reconstruction may be impractical to perform or too costly in terms of patient donor-site morbidity. The field of tissue engineering has long held promise to alleviate these shortcomings. Scaffolds are the structural building blocks of tissue-engineered constructs, akin to the extracellular matrix within native tissues. Commonly used scaffolds include allogenic or xenogenic decellularized tissue, synthetic or naturally derived hydrogels, and synthetic biodegradable nonhydrogel polymeric scaffolds. Embryonic, induced pluripotent, and mesenchymal stem cells also hold immense potential for regenerative purposes. Chemical signals including growth factors and cytokines may be harnessed to augment wound healing and tissue regeneration. Tissue engineering is already clinically prevalent in the fields of breast augmentation and reconstruction, skin substitutes, wound healing, auricular reconstruction, and bone, cartilage, and nerve grafting. Future directions for tissue engineering in plastic surgery include the development of prevascularized constructs and rationally designed scaffolds, the use of stem cells to regenerate organs and tissues, and gene therapy.
Collapse
Affiliation(s)
- Alyssa Reiffel Golas
- Division of Plastic Surgery, Weill Cornell Medical College, 525 E 68th Street, Payson 709A, New York, NY, 10065, USA.
| | - Karina A Hernandez
- Division of Plastic Surgery, Weill Cornell Medical College, 525 E 68th Street, Payson 709A, New York, NY, 10065, USA
| | - Jason A Spector
- Division of Plastic Surgery, Weill Cornell Medical College, 525 E 68th Street, Payson 709A, New York, NY, 10065, USA
| |
Collapse
|
22
|
Crowley C, Birchall M, Seifalian AM. Trachea transplantation: from laboratory to patient. J Tissue Eng Regen Med 2014; 9:357-67. [DOI: 10.1002/term.1847] [Citation(s) in RCA: 67] [Impact Index Per Article: 6.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Affiliation(s)
- Claire Crowley
- UCL Centre for Nanotechnology and Regenerative Medicine; University College; London UK
- Royal National Throat, Nose and Ear Hospital and UCL Ear Institute; London UK
| | - Martin Birchall
- UCL Centre for Nanotechnology and Regenerative Medicine; University College; London UK
- Royal National Throat, Nose and Ear Hospital and UCL Ear Institute; London UK
| | - Alexander M. Seifalian
- UCL Centre for Nanotechnology and Regenerative Medicine; University College; London UK
- Royal Free London NHS Foundation Trust Hospital; London UK
| |
Collapse
|
23
|
Baiguera S, D’Innocenzo B, Macchiarini P. Current status of regenerative replacement of the airway. Expert Rev Respir Med 2014; 5:487-94. [DOI: 10.1586/ers.11.42] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
|
24
|
Tsao CK, Ko CY, Yang SR, Yang CY, Brey EM, Huang S, Chu IM, Cheng MH. An ectopic approach for engineering a vascularized tracheal substitute. Biomaterials 2013; 35:1163-75. [PMID: 24239301 DOI: 10.1016/j.biomaterials.2013.10.055] [Citation(s) in RCA: 30] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/26/2013] [Accepted: 10/19/2013] [Indexed: 02/07/2023]
Abstract
Tissue engineering can provide alternatives to current methods for tracheal reconstruction. Here we describe an approach for ectopic engineering of vascularized trachea based on the implantation of co-cultured scaffolds surrounded by a muscle flap. Poly(L-lactic-co-glycolic acid) (PLGA) or poly(ε-caprolactone) (PCL) scaffolds were seeded with chondrocytes, bone marrow stem cells and co-cultured both cells respectively (8 groups), wrapped in a pedicled muscle flap, placed as an ectopic culture on the abdominal wall of rabbits (n = 24), and harvested after two and four weeks. Analysis of the biochemical and mechanical properties demonstrated that the PCL scaffold with co-culture cells seeding displayed the optimal chondrogenesis with adequate rigidity to maintain the cylindrical shape and luminal patency. Histological analysis confirmed that cartilage formed in the co-culture groups contained a more homogeneous and higher extracellular matrix content. The luminal surfaces appeared to support adequate epithelialization due to the formation of vascularized capsular tissue. A prefabricated neo-trachea was transferred to the defect as a tracheal replacement and yielded satisfactory results. These encouraging results indicate that our co-culture approach may enable the development of a clinically applicable neo-trachea.
Collapse
Affiliation(s)
- Chung-Kan Tsao
- Division of Reconstructive Microsurgery, Department of Plastic and Reconstructive Surgery, Chang Gung Memorial Hospital, Chang Gung University, College of Medicine, Taoyuan, Taiwan
| | | | | | | | | | | | | | | |
Collapse
|
25
|
|
26
|
Regenerative Therapies-Trachea. Regen Med 2013. [DOI: 10.1007/978-94-007-5690-8_33] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
|
27
|
Brouwer KM, Hoogenkamp HR, Daamen WF, van Kuppevelt TH. Regenerative medicine for the respiratory system: distant future or tomorrow's treatment? Am J Respir Crit Care Med 2012; 187:468-75. [PMID: 23220914 DOI: 10.1164/rccm.201208-1558pp] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
Regenerative medicine (RM) is a new field of biomedical science that focuses on the regeneration of tissues and organs and the restoration of organ function. Although regeneration of organ systems such as bone, cartilage, and heart has attracted intense scientific research over recent decades, RM research regarding the respiratory system, including the trachea, the lung proper, and the diaphragm, has lagged behind. However, the last 5 years have witnessed novel approaches and initial clinical applications of tissue-engineered constructs to restore organ structure and function. In this regard, this article briefly addresses the basics of RM and introduces the key elements necessary for tissue regeneration, including (stem) cells, biomaterials, and extracellular matrices. In addition, the current status of the (clinical) application of RM to the respiratory system is discussed, and bottlenecks and recent approaches are identified. For the trachea, several initial clinical studies have been reported and have used various combinations of cells and scaffolds. Although promising, the methods used in these studies require optimization and standardization. For the lung proper, only (stem) cell-based approaches have been probed clinically, but it is becoming apparent that combinations of cells and scaffolds are required to successfully restore the lung's architecture and function. In the case of the diaphragm, clinical applications have focused on the use of decellularized scaffolds, but novel scaffolds, with or without cells, are clearly needed for true regeneration of diaphragmatic tissue. We conclude that respiratory treatment with RM will not be realized tomorrow, but its future looks promising.
Collapse
Affiliation(s)
- Katrien M Brouwer
- Department of Biochemistry, Nijmegen Centre for Molecular Life Sciences, Radboud University Medical Centre, Nijmegen, The Netherlands
| | | | | | | |
Collapse
|
28
|
Orlando G, Wood KJ, De Coppi P, Baptista PM, Binder KW, Bitar KN, Breuer C, Burnett L, Christ G, Farney A, Figliuzzi M, Holmes JH, Koch K, Macchiarini P, Mirmalek Sani SH, Opara E, Remuzzi A, Rogers J, Saul JM, Seliktar D, Shapira-Schweitzer K, Smith T, Solomon D, Van Dyke M, Yoo JJ, Zhang Y, Atala A, Stratta RJ, Soker S. Regenerative medicine as applied to general surgery. Ann Surg 2012; 255:867-80. [PMID: 22330032 PMCID: PMC3327776 DOI: 10.1097/sla.0b013e318243a4db] [Citation(s) in RCA: 70] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
The present review illustrates the state of the art of regenerative medicine (RM) as applied to surgical diseases and demonstrates that this field has the potential to address some of the unmet needs in surgery. RM is a multidisciplinary field whose purpose is to regenerate in vivo or ex vivo human cells, tissues, or organs to restore or establish normal function through exploitation of the potential to regenerate, which is intrinsic to human cells, tissues, and organs. RM uses cells and/or specially designed biomaterials to reach its goals and RM-based therapies are already in use in several clinical trials in most fields of surgery. The main challenges for investigators are threefold: Creation of an appropriate microenvironment ex vivo that is able to sustain cell physiology and function in order to generate the desired cells or body parts; identification and appropriate manipulation of cells that have the potential to generate parenchymal, stromal and vascular components on demand, both in vivo and ex vivo; and production of smart materials that are able to drive cell fate.
Collapse
Affiliation(s)
- Giuseppe Orlando
- Wake Forest Institute for Regenerative Medicine, Winston Salem, NC, USA.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
29
|
Badylak SF. Invited commentary. Ann Thorac Surg 2012; 93:1093. [PMID: 22450064 DOI: 10.1016/j.athoracsur.2012.02.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/31/2012] [Revised: 01/31/2012] [Accepted: 02/02/2012] [Indexed: 10/28/2022]
Affiliation(s)
- Stephen F Badylak
- Department of Surgery, University of Pittsburgh, McGowan Institute for Regenerative Medicine, 450 Technology Dr, Ste 300, Pittsburgh, PA 15219, USA.
| |
Collapse
|
30
|
|
31
|
Vrana NE, Dupret-Bories A, Bach C, Chaubaroux C, Coraux C, Vautier D, Boulmedais F, Haikel Y, Debry C, Metz-Boutigue MH, Lavalle P. Modification of macroporous titanium tracheal implants with biodegradable structures: tracking in vivo integration for determination of optimal in situ epithelialization conditions. Biotechnol Bioeng 2012; 109:2134-46. [PMID: 22331657 DOI: 10.1002/bit.24456] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/19/2011] [Revised: 01/18/2012] [Accepted: 01/26/2012] [Indexed: 01/22/2023]
Abstract
Previously, we showed that macroporous titanium implants, colonized in vivo together with an epithelial graft, are viable options for tracheal replacement in sheep. To decrease the number of operating steps, biomaterial-based replacements for epithelial graft and intramuscular implantation were developed in the present study. Hybrid microporous PLLA/titanium tracheal implants were designed to decrease initial stenosis and provide a surface for epithelialization. They have been implanted in New Zealand white rabbits as tracheal substitutes and compared to intramuscular implantation samples. Moreover, a basement membrane like coating of the implant surface was also designed by Layer-by-Layer (LbL) method with collagen and alginate. The results showed that the commencement of stenosis can be prevented by the microporous PLLA. For determination of the optimum time point of epithelialization after implantation, HPLC analysis of blood samples, C-reactive protein (CRP), and Chromogranin A (CGA) analyses and histology were carried out. Following 3 weeks the implant would be ready for epithelialization with respect to the amount of tissue integration. Calcein-AM labeled epithelial cell seeding showed that after 3 weeks implant surfaces were suitable for their attachment. CRP readings were steady after an initial rise in the first week. Cross-linked collagen/alginate structures show nanofibrillarity and they form uniform films over the implant surfaces without damaging the microporosity of the PLLA body. Human respiratory epithelial cells proliferated and migrated on these surfaces which provided a better alternative to PLLA film surface. In conclusion, collagen/alginate LbL coated hybrid PLLA/titanium implants are viable options for tracheal replacement, together with in situ epithelialization.
Collapse
Affiliation(s)
- Nihal Engin Vrana
- Institut National de la Santé et de la Recherche Médicale, INSERM Unité 977, 11 Rue Humann, 67085 Strasbourg, France
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
32
|
Overview of Tracheal Tissue Engineering: Clinical Need Drives the Laboratory Approach. Ann Biomed Eng 2011; 39:2091-113. [DOI: 10.1007/s10439-011-0318-1] [Citation(s) in RCA: 44] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/13/2010] [Accepted: 04/22/2011] [Indexed: 11/25/2022]
|